Click here for slides on this topic


Diuretics

Antihypertensive agents that help rid the body of sodium and water. The sodium, in turn, takes water with it from your blood. Three types: loop diuretic, thiazide-type diuretics, and potassium-sparing diuretics.
The following content matched the glossary term: Diuretics

Managing the Patient With Type 2 Diabetes and Heart Failure

Top

.style1 FONT FAMILY Arial, Helvetica, sans serif COLOR #004685

ADA 2016 Cardiovascular Disease (CVD) and Diabetes

Top

Recommendations for CVD management, including lipids and BP, in patients with type 2 diabetes from the 2016 ADA diabetes guidelines

An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients

Top

Koro CE, Fu Q, Stender M. An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients. Pharmacoepidemiol Drug Saf. 2008;17(10):989-986. PURPOSE: To determine the likelihood of myocardial infarction (MI) in type 2 diabetic patients exposed to rosiglitazone and pioglitazone, separately, compared to other antidiabetic therapies.

The Importance of Blood Pressure Control in the Patient With Diabetes

Top

Bakris GL. The Importance of Blood Pressure Control in the Patient With Diabetes. Am J Med. 2004;116(Suppl 5A):30S-38S. In individuals with diabetes mellitus, higher risk for renal and cardiovascular disease is seen with blood pressure levels >130/80 mm Hg. Findings of several studies, as well as new guidelines, indicate that individuals with diabetes will benefit from more aggressive treatment of hypertension.

Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP)

Top

Niklason A, Hedner T, Niskanen L, Lanke J. Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens. 2004;22:645-652. The Captopril Prevention Project (CAPPP) was designed as a prospective intervention trial comparing the effect of a treatment based on the angiotensin-converting enzyme (ACE) inhibitor captopril with that of a conventional diuretic and/or beta-blocker-based therapy, in 10,985 hypertensive patients.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Top

Chobanian AV, Bakris GL, Black HR, et al.. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2571. (1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP.

Reduced Cardiovascular Morbidity & Mortality in Hypertensive Diabetic Patients on First-Line Therapy w/ ACE Inhibitor Compared w/ Diuretic b-Blocker-Based

Top

Niskanen L, Hedner T, Hansson L, et al. Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/Beta-Blocker-Based Treatment Regimen. Diabetes Care. 2001;24:2091-2096. The Captopril Prevention Project (CAPPP) evaluated the effects of an ACE inhibitor-based therapeutic regimen on cardiovascular mortality and morbidity in hypertension. One planned subanalysis of the CAPPP was to evaluate the outcome in the diabetic patient group.

Controlling BP in Hypertensive Diabetic Patients Reduces the Risk of Cardiovascular Events & Mortality Regardless of the First-line Antihypertensive Agent

Top

Grossman E, et al. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med. 2000;160:2447-2452. OBJECTIVE: To analyze the available data to assess the benefits of antihypertensive therapy in hypertensive patients with diabetes mellitus.

In Hypertensive Diabetic Patients, ACE Inhibitors Lower Blood Pressure, Reduce the Risk of CVD Events, and Lower the Overall Mortality Rate

Top

Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care. 2000;23:888-892. To assess whether ACE inhibitors are superior to alternative agents for the prevention of cardiovascular events in patients with hypertension and type 2 diabetes.



Slide Library Results

Search Results for: Diuretics Slides Found: 14
ALLHAT: Clinical Outcomes in Antihypertensive Treatments
ADOPT: Adverse Events
RENAAL: Design, Hypothesis, and Baseline Demographics
Compelling Indications for Hypertension Drug Classes
RENAAL: Impact of Losartan in Chronic Kidney Disease
RENAAL: Risk Reduction With Losartan--Design
Compelling Indications for Hypertension Drug Classes (1 of 2)
TINSAL-T2D Trial: Baseline Characteristics
ESH/ESC Hypertension Guidelines: Compelling Indications for Hypertension Treatment
ESH/ESC Hypertension Guidelines: Hypertension Treatment Options
ESH/ESC Hypertension Guidelines: Hypertension Treatment in the Elderly
ESH/ESC Hypertension Guidelines: Hypertension Treatment for People With Metabolic Syndrome
ESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Heart Disease
ESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Atherosclerosis, Arteriosclerosis, and PAD